Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6809367 | 7419718 | F | 6809367-8 | 20100601 | 20100618 | 20100630 | EXP | AU-CELGENEUS-008-50794-10060379 | CELGENEUS | 75 | YR | M | Y | 20100630 | MD | AUSTRALIA |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
6809367 | 1014003084 | PS | VIDAZA | 1 | OTHER | 050794 | |||||
6809367 | 1014003085 | C | SIMVASTATIN | 1 | ORAL | ||||||
6809367 | 1014003086 | C | KARVEA | 2 | ORAL | ||||||
6809367 | 1014003087 | C | ASPIRIN | 1 | ORAL | ||||||
6809367 | 1014003088 | C | ALLOPURINOL | 2 | ORAL |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
6809367 | 1014003085 | BLOOD CHOLESTEROL ABNORMAL |
6809367 | 1014003086 | HYPERTENSION |
6809367 | 1014003087 | CEREBROVASCULAR ACCIDENT |
6809367 | 1014003088 | PROPHYLAXIS |
Outcome of event
Event ID | OUTC COD |
---|---|
6809367 | HO |
Reactions reported
Event ID | PT |
---|---|
6809367 | TUMOUR LYSIS SYNDROME |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
6809367 | 1014003084 | 20100531 | 20100608 | 8 | DAY |
6809367 | 1014003087 | 20100601 | |||
6809367 | 1014003088 | 20100531 |